Basic Information
92Bio Develops Novel, First-Class Multispecific Biologics for Cancer Treatment. By leveraging cutting-edge technology and deep insights into oncology, the company is committed to revolutionizing antibody development and ultimately transforming treatment outcomes.
92Bio, Inc.
California,United States of America
unclear
--
info@92biotech.com
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios